TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Cannabis Investors: Is Owning Horizons Marijuana Life Sciences Idx ETF Safer Than Picking Your Own Pot Stocks?
Investing
My 2018 Prediction for the Canadian Cannabis Industry
Investing
Canopy Growth Corp.: Is This Stock Worth a Shot?
Investing
Why More Medical Marijuana IPOs Are Coming and Why You Should Avoid Them
Investing
No Brainer: Buy and Hold Marijuana Stocks
Investing
A Safe Way to Play the Resurgence of Canadian Cannabis Stocks
Dividend Stocks
Why the Legalization of Marijuana Will Have a Negative Impact on These REITs
Top TSX Stocks
Where Are Canadian Marijuana Stocks Headed From Here?
Investing
Why Canopy Growth Corp. Will Become Great Again in the Eyes of Investors
Investing
How Well Are Canadian Cannabis Companies Managing Recall Risks?
Investing
Higher Interest Rates Make Marijuana Stocks a Riskier Investment